Skip to main
NHI
NHI logo

NHI Stock Forecast & Price Target

NHI Analyst Ratings

Based on 5 analyst ratings
Buy
Strong Buy 20%
Buy 60%
Hold 20%
Sell 0%
Strong Sell 0%

Bulls say

National Health Investors Inc. has demonstrated strong operational performance, with an increase in normalized Funds From Operations (NFFO) estimates for 2025, rising to $4.80 per share, which aligns with management's guidance range and exceeds the FactSet core FFO estimate. The positive outlook is further supported by an increase in the 2026 FFO estimate to $5.03 per share, which is slightly above consensus expectations, indicating strong management and operational effectiveness. Overall, the company's revenue streams from both the Real Estate Investments and Senior Housing Operating Portfolio segments position it favorably for continued financial growth.

Bears say

The financial outlook for National Health Investors Inc. is negatively impacted by anticipated lower earnings growth over the next few years, which is attributed to potential operator issues and transitions affecting revenue generation. Additionally, concerns regarding rent resets, particularly related to NHC, may lead to underperformance if they fall below investor expectations. Furthermore, risks associated with deferred rent collections and the potential for operators facing operational challenges, possibly exacerbated by future health crises, contribute to the company's unfavorable financial projections.

NHI has been analyzed by 5 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 60% recommend Buy, 20% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of National Health Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About National Health Investors (NHI) Forecast

Analysts have given NHI a Buy based on their latest research and market trends.

According to 5 analysts, NHI has a Buy consensus rating as of Dec 15, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

National Health Investors (NHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.